tility of CB-NAAT (a diagnostic test) in diagnosing cases of skin tuberculosis.
Not Applicable
Completed
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2019/02/017549
- Lead Sponsor
- King Georges Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 44
Inclusion Criteria
(a) Patients clinically diagnosed as cutaneous TB and who give consent to participate in
the study
Exclusion Criteria
(a) Who have taken ATT in last one year
(b) Contra-indication for biopsy or FNAC like bleeding and clotting disorders
(c) Patients with severe debilitating and chronic illness like Hepatitis B,C, malignancy,
uncontrolled diabetes etc
(d) Not willing to participate in study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess and compare the efficacy of CBNAAT, culture and histopathological <br/ ><br>examination (including staining for AFB) in diagnosing cases of cutaneous TB.Timepoint: 1.5 years
- Secondary Outcome Measures
Name Time Method Assessment and comparison of Rifampicin resistance results shown <br/ ><br>by CBNAAT and DST (for cases that show culture growth).Timepoint: 1.5 years